| Previous Close | 242.25 |
| Open | 240.54 |
| Bid | 244.62 x 900 |
| Ask | 244.93 x 900 |
| Day's Range | 239.37 - 246.80 |
| 52 Week Range | 132.24 - 246.80 |
| Volume | |
| Avg. Volume | 1,101,236 |
| Market Cap | 35.603B |
| Beta (5Y Monthly) | 0.66 |
| PE Ratio (TTM) | 34.97 |
| EPS (TTM) | 6.93 |
| Earnings Date | Oct 24, 2024 - Oct 28, 2024 |
| Forward Dividend & Yield | 2.12 (0.88%) |
| Ex-Dividend Date | Aug 15, 2024 |
| 1y Target Est | 228.04 |
InvestopediaS&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index
The S&P 500 added 0.2% on Tuesday, Aug. 27, ahead of Nvidia's earnings report on Wednesday and key economic data on tap for later in the week.
ZacksWhy This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GlobeNewswireResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
DelOrefice is the Chief Financial Officer at BD, one of the largest global MedTech companies in the worldBoard appointment brings over 30 years of strategic and operational finance expertise SAN DIEGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it has expanded the size of its board of directors to 11 and has elected Christopher DelOrefice to the board, effective immediately. Mr. DelOrefice was appointed during ResMed’s regularly scheduled board meeting on Augu
